Page last updated: 2024-12-07

cyclopropanol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID123361
CHEBI ID188444
MeSH IDM0128330

Synonyms (21)

Synonym
cyclopropanol
hydroxycyclopropane
CHEBI:188444
16545-68-9
cyclopropyl alcohol
unii-tk7n9f9r3y
tk7n9f9r3y ,
AKOS022183551
YOXHCYXIAVIFCZ-UHFFFAOYSA-N
c3h6o
FT-0699490
FT-0698757
DTXSID40167949
mfcd19707103
SY028267
Q3560539
EN300-100685
AMY35209
A858296
SB40661
CS-0059134
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
cyclopropanesCyclopropane and its derivatives formed by substitution.
aliphatic alcoholAn alcohol derived from an aliphatic compound.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (54)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (3.70)18.7374
1990's1 (1.85)18.2507
2000's13 (24.07)29.6817
2010's26 (48.15)24.3611
2020's12 (22.22)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 46.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index46.21 (24.57)
Research Supply Index4.01 (2.92)
Research Growth Index5.76 (4.65)
Search Engine Demand Index65.98 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (46.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (3.70%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other52 (96.30%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]